• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低密度脂蛋白胆固醇目标达标率及韩国糖尿病患者达标情况的医师认知

Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes.

机构信息

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

出版信息

Diabetes Metab J. 2011 Dec;35(6):628-36. doi: 10.4093/dmj.2011.35.6.628. Epub 2011 Dec 26.

DOI:10.4093/dmj.2011.35.6.628
PMID:22247906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3253974/
Abstract

BACKGROUND

This study aims to investigate the discrepancy between clinicians' perceptions and actual achievement rates of low density lipoprotein cholesterol (LDL-C) in Korean patients with diabetes according to updated American Diabetes Association (ADA)/American College of Cardiology Foundation (ACC) recommendations.

METHODS

This is a multi-center, retrospective, non-interventional, observational study. Diabetic patients aged 18 years or older were eligible if they had been diagnosed with hypercholesterolemia or were receiving a lipid-lowering therapy between May 2010 and August 2010. The information was obtained by reviewing medical records and using a self-completed questionnaire to examine physician perceptions.

RESULTS

A total of 2,591 subjects who satisfied the inclusion criteria were enrolled. Highest-risk and high-risk patients accounted for 61.9% and 38.1% of the patients, respectively. Although most (96.3%) underwent a statin monotherapy or a statin-based combination therapy, just 47.4% of patients attained the LDL-C target. However, the physicians' perceptions on target achievement rate (70.6%) were different from the actual results (47.4%). Many patients (65.3%) remained on the starting doses of statins, despite evidence of poor achievement of lipid goals.

CONCLUSION

Only less than half of patients with diabetes attained the LDL-C goal. The surveys showed that poor physician performance might be due to the lack of recognition on ADA/ACC consensus causing a low LDL-C target attainment rate. Therefore, changes in doctor perception are needed to attain target LDL-C level and reduce cardiovascular risk in Korean patients with diabetes.

摘要

背景

本研究旨在根据美国糖尿病协会(ADA)/美国心脏病学会基金会(ACC)的最新建议,调查韩国糖尿病患者的临床医生对低密度脂蛋白胆固醇(LDL-C)的认知与实际达标率之间的差异。

方法

这是一项多中心、回顾性、非干预性、观察性研究。年龄在 18 岁或以上的糖尿病患者,如果在 2010 年 5 月至 2010 年 8 月期间被诊断为高胆固醇血症或正在接受降脂治疗,则符合入选条件。通过查阅病历和使用自我完成的问卷来检查医生的认知,获取信息。

结果

共有 2591 名符合纳入标准的患者入选。高危和高风险患者分别占患者的 61.9%和 38.1%。尽管大多数(96.3%)接受了他汀类药物单一疗法或他汀类药物联合治疗,但只有 47.4%的患者达到了 LDL-C 目标。然而,医生对目标达标率(70.6%)的认知与实际结果(47.4%)不同。尽管血脂目标达标情况较差,但许多患者(65.3%)仍在使用他汀类药物的起始剂量。

结论

只有不到一半的糖尿病患者达到了 LDL-C 目标。调查显示,医生表现不佳可能是由于缺乏对 ADA/ACC 共识的认识,导致 LDL-C 目标达标率较低。因此,需要改变医生的认知,以达到目标 LDL-C 水平并降低韩国糖尿病患者的心血管风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/6f7853044adf/dmj-35-628-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/9e1da277b486/dmj-35-628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/b910e062ef48/dmj-35-628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/2c4b47f07fd7/dmj-35-628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/a5a23369f9aa/dmj-35-628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/b0c201a68df7/dmj-35-628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/6f7853044adf/dmj-35-628-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/9e1da277b486/dmj-35-628-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/b910e062ef48/dmj-35-628-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/2c4b47f07fd7/dmj-35-628-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/a5a23369f9aa/dmj-35-628-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/b0c201a68df7/dmj-35-628-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e968/3253974/6f7853044adf/dmj-35-628-g006.jpg

相似文献

1
Low Density Lipoprotein Cholesterol Target Goal Attainment Rate and Physician Perceptions about Target Goal Achievement in Korean Patients with Diabetes.低密度脂蛋白胆固醇目标达标率及韩国糖尿病患者达标情况的医师认知
Diabetes Metab J. 2011 Dec;35(6):628-36. doi: 10.4093/dmj.2011.35.6.628. Epub 2011 Dec 26.
2
Determinants of low-density lipoprotein cholesterol goal attainment: Insights from the CEPHEUS Pan-Asian Survey.低密度脂蛋白胆固醇目标达标率的决定因素:CEPHEUS 泛亚调查的见解。
J Chin Med Assoc. 2014 Feb;77(2):61-7. doi: 10.1016/j.jcma.2013.10.013. Epub 2013 Dec 11.
3
Current status of cholesterol goal attainment after statin therapy among patients with hypercholesterolemia in Asian countries and region: the Return on Expenditure Achieved for Lipid Therapy in Asia (REALITY-Asia) study.亚洲国家和地区高胆固醇血症患者接受他汀类药物治疗后胆固醇目标达成情况:亚洲脂质治疗支出回报(REALITY-亚洲)研究
Curr Med Res Opin. 2008 Jul;24(7):1951-63. doi: 10.1185/03007990802138731. Epub 2008 Jun 10.
4
Real-life LDL-C treatment goals achievement in patients with heterozygous familial hypercholesterolemia in the Czech Republic and Slovakia: Results of the PLANET registry.捷克共和国和斯洛伐克杂合子家族性高胆固醇血症患者的真实 LDL-C 治疗目标达成情况:PLANET 登记研究结果。
Atherosclerosis. 2018 Oct;277:355-361. doi: 10.1016/j.atherosclerosis.2018.08.008.
5
Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.与其他他汀类药物相比,瑞舒伐他汀降低糖尿病患者低密度脂蛋白胆固醇的有效性及达到美国国家胆固醇教育计划成人治疗小组第三次指南低密度脂蛋白胆固醇目标的情况:一项使用美国电子病历数据集的回顾性研究
Curr Med Res Opin. 2007 Sep;23(9):2125-33. doi: 10.1185/030079907X219580.
6
Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.他汀类药物治疗的糖尿病患者存在严重的高三酰甘油血症和残余血脂异常,这些患者心血管疾病风险最高,且达到非常低的 LDL-C 水平。
J Clin Lipidol. 2012 Sep-Oct;6(5):434-42. doi: 10.1016/j.jacl.2012.04.002. Epub 2012 Apr 12.
7
Lipid-Lowering Therapy and Low-Density Lipoprotein Cholesterol (LDL-C) Goal Achievement in High-Cardiovascular-Risk Patients in Fuzhou, China.降脂治疗与中国福州高危心血管风险患者的低密度脂蛋白胆固醇(LDL-C)目标达标情况。
J Cardiovasc Pharmacol Ther. 2020 Jul;25(4):307-315. doi: 10.1177/1074248419899298. Epub 2020 Jan 10.
8
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular disease.与他汀类药物效力以及依折麦布/辛伐他汀联合疗法相关的治疗实践模式对高危心血管疾病患者低密度脂蛋白胆固醇(LDL-C)的降低作用
J Clin Lipidol. 2014 Jan-Feb;8(1):107-16. doi: 10.1016/j.jacl.2013.09.009. Epub 2013 Oct 1.
9
Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.在管理式医疗环境中,以低高密度脂蛋白胆固醇为靶点降低残余心血管风险。
J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1.
10
Target achievement with maximal statin-based lipid-lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis.韩国家族性高胆固醇血症患者采用最大剂量他汀类药物降脂治疗的目标达成情况:一项由韩国脂质与动脉粥样硬化学会支持的研究
Clin Cardiol. 2017 Dec;40(12):1291-1296. doi: 10.1002/clc.22826. Epub 2017 Dec 14.

引用本文的文献

1
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.韩国2型糖尿病患者的血脂管理:韩国糖尿病协会和韩国脂质与动脉粥样硬化学会共识声明
J Lipid Atheroscler. 2023 Jan;12(1):12-22. doi: 10.12997/jla.2023.12.1.12. Epub 2023 Jan 17.
2
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement.韩国 2 型糖尿病患者的血脂管理:韩国糖尿病协会和韩国血脂与动脉粥样硬化学会共识声明。
Diabetes Metab J. 2023 Jan;47(1):1-9. doi: 10.4093/dmj.2022.0448. Epub 2023 Jan 20.
3

本文引用的文献

1
2011 clinical practice guidelines for type 2 diabetes in Korea.2011 年韩国 2 型糖尿病临床实践指南。
Diabetes Metab J. 2011 Oct;35(5):431-6. doi: 10.4093/dmj.2011.35.5.431. Epub 2011 Oct 31.
2
Intensive multifactorial intervention improves modelled coronary heart disease risk in screen-detected Type 2 diabetes mellitus: a cluster randomized controlled trial.强化多因素干预可改善筛查出的 2 型糖尿病患者的冠心病风险模型:一项群组随机对照试验。
Diabet Med. 2012 Apr;29(4):531-40. doi: 10.1111/j.1464-5491.2011.03441.x.
3
Team-based care approach to cholesterol management in diabetes mellitus: two-year cluster randomized controlled trial.
Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines.
韩国 2 型糖尿病患者的低密度脂蛋白胆固醇目标达标现状与近期指南比较。
Diabetes Metab J. 2021 May;46(3):464-475. doi: 10.4093/dmj.2021.0088. Epub 2022 Mar 3.
4
Dyslipidemia and Rate of Under-Target Low-Density Lipoprotein-Cholesterol in Patients with Coronary Artery Disease in Korea.韩国冠心病患者的血脂异常与低密度脂蛋白胆固醇未达目标水平的发生率
J Lipid Atheroscler. 2019 Sep;8(2):242-251. doi: 10.12997/jla.2019.8.2.242. Epub 2019 Aug 12.
5
Achievement of LDL-C Targets Defined by ESC/EAS (2011) Guidelines in Risk-Stratified Korean Patients with Dyslipidemia Receiving Lipid-Modifying Treatments.根据 ESC/EAS(2011)指南,在接受调脂治疗的血脂异常风险分层韩国患者中实现 LDL-C 目标。
Endocrinol Metab (Seoul). 2020 Jun;35(2):367-376. doi: 10.3803/EnM.2020.35.2.367. Epub 2020 Jun 24.
6
Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.韩国心血管疾病和糖尿病高危患者的低密度脂蛋白胆固醇目标达标率:一项回顾性队列研究。
Lipids Health Dis. 2020 Jan 11;19(1):5. doi: 10.1186/s12944-019-1158-5.
7
Trends in the management levels of metabolic risk factors in middle-aged and elderly patients with type 2 diabetes mellitus: The Korean National Health and Nutrition Examination Survey 1998-2014.1998 - 2014年韩国国民健康与营养检查调查:2型糖尿病中老年患者代谢危险因素管理水平的趋势
PLoS One. 2017 Dec 11;12(12):e0189361. doi: 10.1371/journal.pone.0189361. eCollection 2017.
8
Effect of physician characteristics and knowledge on the quality of dyslipidemia management and LDL-C target goal achievement in China: Subgroup analysis of the Dyslipidemia International Study.医生特征和知识对中国血脂异常管理质量及低密度脂蛋白胆固醇(LDL-C)目标达成的影响:血脂异常国际研究的亚组分析
J Glob Health. 2017 Dec;7(2):020702. doi: 10.7189/jogh.07.020702.
9
Achievement of LDL Cholesterol Goal and Adherence to Statin by Diabetes Patients in Kelantan.吉兰丹州糖尿病患者的低密度脂蛋白胆固醇目标达成情况及他汀类药物依从性
Malays J Med Sci. 2017 May;24(3):44-50. doi: 10.21315/mjms2016.24.3.6. Epub 2017 Jun 30.
10
Physicians' behavior following changes in LDL cholesterol target goals.低密度脂蛋白胆固醇目标值改变后医生的行为。
Isr J Health Policy Res. 2015 Jun 1;4:20. doi: 10.1186/s13584-015-0016-9. eCollection 2015.
基于团队的糖尿病患者胆固醇管理方法:两年整群随机对照试验
Arch Intern Med. 2011 Sep 12;171(16):1480-6. doi: 10.1001/archinternmed.2011.417.
4
Diabetes and cardiovascular disease.糖尿病与心血管疾病。
Diabetes Care. 2011 Mar;34(3):e24-30. doi: 10.2337/dc11-0007.
5
Standards of medical care in diabetes--2011.《糖尿病医疗护理标准——2011 年》
Diabetes Care. 2011 Jan;34 Suppl 1(Suppl 1):S11-61. doi: 10.2337/dc11-S011.
6
Is diabetes a coronary risk equivalent? Systematic review and meta-analysis.糖尿病是否等同于冠心病风险?系统评价与荟萃分析。
Diabet Med. 2009 Feb;26(2):142-8. doi: 10.1111/j.1464-5491.2008.02640.x.
7
Lipoprotein management in patients with cardiometabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation.心血管代谢风险患者的脂蛋白管理:美国糖尿病协会和美国心脏病学会基金会的共识声明
Diabetes Care. 2008 Apr;31(4):811-22. doi: 10.2337/dc08-9018.
8
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study.
Circ J. 2008 Jan;72(1):17-22. doi: 10.1253/circj.72.17.
9
Contemporary management of dyslipidemia in high-risk patients: targets still not met.高危患者血脂异常的当代管理:目标仍未达成。
Am J Med. 2006 Aug;119(8):676-83. doi: 10.1016/j.amjmed.2005.11.015.
10
The control of dyslipidemia in outpatient clinics in Greece (OLYMPIC) Study.希腊门诊血脂异常控制(OLYMPIC)研究
Angiology. 2005 Nov-Dec;56(6):731-41. doi: 10.1177/000331970505600611.